Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials
2023-08-11 21:00
Nano Labs to Announce First Half of 2023 Financial Results on August 15, 2023
2023-08-11 20:00
Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer
2023-08-11 17:00
Move Aside Anti-Ageing, It's Age Reversal We're Talking Now
2023-08-11 13:49
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
2023-08-11 11:14
WuXi XDC and Boostimmune Sign MOU for Integrated Services
2023-08-11 08:30
WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services
2023-08-11 08:30
Antengene Enters into Commercialization Partnership with Hansoh Pharma for First/Only-in-Class XPO1 Inhibitor XPOVIO®(selinexor) in the Mainland of China
2023-08-11 08:00
JUNG KWAN JANG Red Ginseng Samgyetang, a popular energizing food for hot summer days
2023-08-11 08:00
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients
2023-08-11 07:18
YS Biopharma to Report First Quarter Fiscal Year 2024 Financial Results on August 15, 2023
2023-08-11 04:30
Datasea Launches Innovative "Intelligent Acoustics" Subsidiary in Delaware, Unveiling AI-Integrated Offerings for US Market
2023-08-10 21:30
HitGen Enters into DNA-Encoded Library Based Research Service Agreement with Nested Therapeutics
2023-08-10 21:30
Standigm and Nashville Biosciences join to revolutionize early drug discovery
2023-08-10 21:07
Oricell OriCAR-017 CAR-T Therapy Clears IND Hurdle, Paving the Way for Global Impact
2023-08-10 21:00
Clarity's theranostic prostate cancer trial advances to highest dose level
2023-08-10 20:58
Waterdrop Presents Advanced Digital Risk Management Solution at 2023 Inslab Insurance Technology Festival
2023-08-10 19:41
LyondellBasell Awarded the 2023 Global Medical Plastics Company of the Year by Frost & Sullivan
2023-08-10 19:00
Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation
2023-08-10 19:00
AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
2023-08-10 15:49
1
138
139
140
141
142
1524